Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival

Jia, Min ; Zhang, Yan ; Jansen, Lina ; Walter, Viola ; Edelmann, Dominic ; Gündert, Melanie ; Tagscherer, Katrin E. ; Roth, Wilfried ; Bewerunge-Hudler, Melanie ; Herpel, Esther ; Kloor, Matthias ; Ulrich, Alexis ; Burwinkel, Barbara ; Bläker, Hendrik ; Chang-Claude, Jenny ; Brenner, Hermann ; Hoffmeister, Michael

In: Clinical Epigenetics, 11 (2019), Nr. 109. pp. 1-11. ISSN 1868-7083

[img] PDF, English - main document
Download (1MB) | Lizenz: Creative Commons LizenzvertragA prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival by Jia, Min ; Zhang, Yan ; Jansen, Lina ; Walter, Viola ; Edelmann, Dominic ; Gündert, Melanie ; Tagscherer, Katrin E. ; Roth, Wilfried ; Bewerunge-Hudler, Melanie ; Herpel, Esther ; Kloor, Matthias ; Ulrich, Alexis ; Burwinkel, Barbara ; Bläker, Hendrik ; Chang-Claude, Jenny ; Brenner, Hermann ; Hoffmeister, Michael underlies the terms of Creative Commons Attribution 4.0

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Results of previous studies on the association of the CpG island methylator phenotype (CIMP) with colorectal cancer (CRC) prognosis were inconsistent and mostly based on different CIMP definitions. The current study aimed to comprehensively investigate the associations between DNA methylation on genes previously used to define CIMP status with CRC survival.

Results: Patients with CRC followed up for a median of 5.2 years were divided into a study cohort (n = 568) and a validation cohort (n = 308). DNA methylation was measured in tumor tissue using the Illumina Infinium HumanMethylation450 BeadChip and restricted to 43 genes used to define CIMP status in previous studies. Cox proportional hazard regression models were used to estimate adjusted hazard ratios (HR) and 95% confidence intervals (CI) of survival after CRC, including adjustment for tumor stage, microsatellite instability, and BRAF mutation status. In the study cohort, ten CpG sites were identified to be associated with CRC survival. Seven of these ten CpG sites were also associated with CRC survival in the validation cohort and were used to construct a prognostic score. CRC patients with a prognostic score of the lowest methylation level showed poorer disease-specific survival compared with patients with the highest methylation level in both the study cohort and the validation cohort (HR = 3.11 and 95% CI = 1.97–4.91, and HR = 3.06 and 95% CI = 1.71–5.45, respectively).

Conclusions: A CpG panel consisting of seven CpG sites was found to be strongly associated with CRC survival, independent from important clinical factors and mutations associated with CIMP. Further studies are required to confirm these findings.

Item Type: Article
Journal or Publication Title: Clinical Epigenetics
Volume: 11
Number: 109
Publisher: BioMed Central ; Springer
Place of Publication: London ; Berlin, Heidelberg
Date Deposited: 20 Aug 2019 12:21
Date: 2019
ISSN: 1868-7083
Page Range: pp. 1-11
Faculties / Institutes: Service facilities > German Cancer Research Center (DKFZ)
Medizinische Fakultät Heidelberg > Pathologisches Institut
Subjects: 610 Medical sciences Medicine
Uncontrolled Keywords: Colorectal cancer, Survival, DNA methylation, CpG site, Prognosis
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative